The first time Caroline went on Wegovy, it was hardly a secret. She told her boyfriend, her mother, and her close friends about the decision. Over the course of six months, they watched as she shed 30 pounds, bringing her down from 130 pounds to what she calls her “healthy original weight” of 100 pounds. Even still, her loved ones worried about the extent of her rapid weight loss and actively discouraged her from dropping any further.
“I had tried every way under the sun to lose weight,” Caroline tells SELF. The 34-year-old Montreal resident, who asked to use only her first name to protect her privacy, admits she was simply exhausted by the relentless cycle of dieting. Standing five feet and four inches tall, she was never clinically obese and correctly suspected that her primary care physician would decline to approve a prescription for a powerful anti-obesity medication.
Undeterred, she turned to the internet and found a telehealth doctor who prescribed the medication over the phone, unaware of Caroline’s actual weight or medical history. Immediately after starting Wegovy, she recalls, the weight began coming off at an astonishing pace. After six months, she decided she had reached her goal and stopped taking the drug. But the rebound was swift and punishing: she gained 10 pounds in a single month.
“I realized, I can’t stop,” Caroline says.
For the past six months, she has been taking Wegovy again, this time at a maintenance-level dosage to keep the weight from returning. But there is one major difference: this time, she is keeping the treatment a complete secret from her boyfriend and family.
Now that the couple is actively discussing marriage and children, her boyfriend has witnessed the physical and emotional impacts of her first round on the drug and made it clear he is finished with it, she explains. Because she lives alone, hiding her medication is relatively straightforward. She stashes the injectable pens in the back of her refrigerator, where they must be kept cold to remain potent.
Yet the deception creates immense logistical anxiety. When they travel together, she is forced to conceal the medication in hotel room mini-fridges. When visiting his parents, she has to sneak the pens into their household refrigerator.
“So imagine, I’m hiding stuff in my parents-in-laws’ fridge, hoping they won’t see them,” she says. “It’s super awkward.”
Caroline is far from alone in going to elaborate lengths to keep her GLP-1 use under wraps. On a recent discussion thread on the popular online forum r/GLP1microdosing, women swapped elaborate tips and concealment strategies for hiding their refrigerated medication from spouses and family members. One user stashes her pens inside a tomato paste box. Another hides them within a play food container from a child’s pretend kitchen.
Others have turned to an opaque feta cheese container, a butter stick box, an anchovy paste box, empty bottles of women’s probiotics, vitamin supplements, plastic take-out containers, metal water bottles, boxed wine packaging, and baking soda boxes tucked safely in the darkest corners of the refrigerator—all to conceal the powerful weight-loss medication from prying eyes.
“It’s a real thing,” says Dr. Kia Mitchell, a family and obesity medicine physician practicing in Jacksonville, Florida, who spoke with SELF. Dr. Mitchell has treated numerous women in her practice who go to similar, exhausting efforts to hide their medication from domestic partners. The first time she encountered the phenomenon, it was from a patient who simply wanted to avoid a prolonged household debate and retain the personal option to take her medication.
“A lot of my patients are similar,” Dr. Mitchell adds. “There’s this loss of control with the gaining of the weight, but being able to control the narrative around weight loss has been empowering and exciting for her patients. Because now they can reveal it on their own terms. That’s where the control comes back.”
The underlying motivations for this secrecy are vividly illustrated in online community forums. Users frequently cite the dread of unsolicited lectures and critical commentary from loved ones who harbor skepticism or fear regarding GLP-1 receptor agonists.
“If my husband found out, it would just be a series of lectures,” wrote one user named Vivid-Act-6442. Another user noted a simple desire to avoid negative opinions accumulated over decades of marriage. Another woman confessed to hiding her medications from her teenage children out of fear they would report back to her ex-husband, simply wishing to avoid an interrogation about her health choices.
Dr. Mitchell holds mixed feelings about this pervasive secrecy. Anyone embarking on a challenging health journey ultimately benefits from a support network that roots for their success, she notes, emphasizing that patients need community. At the same time, she acknowledges that retaining the autonomy to decide who knows about one’s medical treatments is empowering and protective—even if the ideal scenario involves absolute trust within a romantic partnership.
From a clinical perspective, however, concealing GLP-1 use from a significant other carries tangible medical risks. These medications can significantly enhance fertility, making unplanned pregnancies more likely while on the drug; Dr. Mitchell notes she has several "GLP-1 babies" delivered by patients in her practice. Furthermore, concealing treatment makes it exceptionally difficult for a patient to seek emotional or practical support from a partner when experiencing uncomfortable gastrointestinal side effects.
More broadly, secrecy exacts a heavy toll in psychological stress. When patients are actively trying to lose weight, physicians prefer to keep stress hormones as low as possible, Dr. Mitchell explains, warning that managing secret regimens creates an avoidable uphill battle against chronic anxiety.
A parallel and perhaps larger medical issue involves hiding GLP-1 medications from primary care physicians—a practice made vastly easier by the proliferation of direct-to-consumer telehealth platforms such as Hers and Ro.
This is precisely the predicament facing Caroline, who withheld her medication use from her primary care doctor during both rounds of treatment. As her annual physical approaches, she remains anxious about how to handle the inevitable questions regarding her significant weight loss, especially because she is also taking Accutane and Ritalin and worries about potential drug interactions. Terrified of breaking trust with her primary physician, she has turned to artificial intelligence for medical advice.
“I use ChatGPT as my doctor at this point since I can’t be honest with my own doctor,” she admits, acknowledging that it is far from an ideal solution. “I say, ‘Hey, this is my actual weight, what type of dosage is okay to take with other drugs?’”
Caroline originally obtained her Wegovy prescription through the telehealth platform Hers, noting that the intake process required only basic bloodwork and provided informational documentation rather than direct clinical counseling.
Dr. Craig Primack, head of weight loss at Hers, tells SELF that prescribing physicians at the company routinely encourage patients to discuss their treatment plans with their primary care providers. While acknowledging that direct clinical counseling is limited, Dr. Primack states that the platform screens for mental health, anxiety, and stress, and offers app-based resources developed by psychologists covering topics like sleep management and eating behaviors.
Dr. Primack confirms that he is well aware of patients hiding their medications from romantic partners. Motivations vary widely: some patients want to prove they can sustain weight loss before revealing their methods; others worry about the substantial out-of-pocket costs; and many fear how the disclosure might alter domestic relationship dynamics.
“Your weight and persona set up a dynamic in your couple,” Dr. Primack explains. “When you start changing that, sometimes spouses get very jealous—‘Oh my god, you’re becoming potentially more attractive.’ Not that weight is directly linked to that, but that’s what I hear them say.”
Beyond interpersonal dynamics, the persistent social stigma surrounding weight and obesity continues to drive patients toward virtual care. Telemedicine successfully removes much of the judgment and societal bias that patients face, acting as a vital bridge for those too uncomfortable to discuss weight management with their traditional doctors, Dr. Primack adds.
Whether Caroline eventually decides to disclose her medication use to her primary physician or her partner, she continues to grapple with the deeper emotional complexities unearthed by her treatment. The secrecy, combined with her dependence on a lifelong injection to maintain her weight, has taken a psychological toll.
“It’s very stressful,” she says. “The fact that not only can I not talk about it, but I’m also unable to get off of it. I don’t love the idea of taking medicine like that forever, but I’m kind of stuck with it.” While she is glad to avoid weight regain, she questions whether her relentless pursuit of a specific physical standard reflects overly harsh self-criticism.
Given the profound vulnerability tied to body image and weight loss, navigating the decision to disclose GLP-1 use to loved ones remains a deeply sensitive dilemma. However, the approach to that conversation can significantly ease the burden, according to Dr. Rachel Goldman, a clinical assistant professor in the department of psychiatry at NYU Grossman School of Medicine whose expertise includes weight management and eating behaviors.
Framing the discussion around personal experiences and individual health needs rather than external expectations helps make the conversation feel manageable and shields the patient from feeling forced into a defensive posture, Dr. Goldman explains.
Before initiating the conversation, Dr. Goldman encourages patients to clarify their underlying motivations by identifying what led them to the decision and what the treatment means for their overall well-being. Grounding oneself in that personal rationale builds the confidence needed for transparent communication. She also recommends drafting conversational scripts centered on personal experience, utilizing "I" statements rather than broad generalizations.
Anticipating a partner’s potential reactions and preparing for various scenarios can also mitigate anxiety. Clarifying what kind of response is needed—whether it is practical support, basic understanding, or simply the space to make health decisions free from judgment—is crucial, Dr. Goldman notes. She reminds patients that initial emotional reactions rarely represent final resolutions, as partners often require time to process new information and work through their own implicit biases.
Ultimately, the objective is not a flawless conversation, but rather opening a pathway toward greater honesty, emotional connection, and mutual support over time. And if all else fails, there remains the quiet refuge of the kitchen refrigerator—behind the box of anchovy paste.
